Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection.
暂无分享,去创建一个
J. Lieberman | J. Andersson | P. Shankar | N. Manjunath | P Shankar | J Lieberman | N Manjunath | J Andersson | Judy Lieberman | Jan Andersson
[1] R. Zinkernagel,et al. Immunological Memory , 2006 .
[2] J. Lieberman,et al. CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. , 2001, Blood.
[3] S. Lonial,et al. Larger numbers of CD4bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation , 2001 .
[4] Todd M. Allen,et al. Functional Impairment of Simian Immunodeficiency Virus-Specific CD8+ T Cells during the Chronic Phase of Infection , 2001, Journal of Virology.
[5] J. Andersson,et al. Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. , 2001, The Journal of clinical investigation.
[6] John Sidney,et al. Identification of Novel HLA-A2-Restricted Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Epitopes Predicted by the HLA-A2 Supertype Peptide-Binding Motif , 2001, Journal of Virology.
[7] E. Rosenberg,et al. Functionally Inert HIV-Specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children , 2000, The Journal of experimental medicine.
[8] V. Shepherd,et al. HIV-1 Tat Represses Transcription from the Mannose Receptor Promoter1 , 2000, The Journal of Immunology.
[9] B. Walker,et al. The Role of CD4+ T Cell Help and CD40 Ligand in the In Vitro Expansion of HIV-1-Specific Memory Cytotoxic CD8+ T Cell Responses , 2000, The Journal of Immunology.
[10] M. Mulligan,et al. A Significant Number of Human Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes Detected by Tetramer Binding Do Not Produce Gamma Interferon , 2000, Journal of Virology.
[11] J. Lieberman,et al. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. , 2000, Blood.
[12] Michael Loran Dustin,et al. Signaling Takes Shape in the Immune System , 2000, Cell.
[13] R. Koup,et al. Putative Immunodominant Human Immunodeficiency Virus-Specific CD8+ T-Cell Responses Cannot Be Predicted by Major Histocompatibility Complex Class I Haplotype , 2000, Journal of Virology.
[14] E. Rosenberg,et al. Immune control of HIV-1 after early treatment of acute infection , 2000, Nature.
[15] Alessandro Sette,et al. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia , 2000, Nature.
[16] J. Lieberman,et al. Human Immunodeficiency Virus-Specific Circulating CD8 T Lymphocytes Have Down-Modulated CD3ζ and CD28, Key Signaling Molecules for T-Cell Activation , 2000, Journal of Virology.
[17] M. Dybul,et al. CD40 Ligand Trimer and IL-12 Enhance Peripheral Blood Mononuclear Cells and CD4+ T Cell Proliferation and Production of IFN-γ in Response to p24 Antigen in HIV-Infected Individuals: Potential Contribution of Anergy to HIV-Specific Unresponsiveness , 2000, The Journal of Immunology.
[18] M. Altfeld,et al. The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1. , 2000, Current opinion in immunology.
[19] J. Lieberman,et al. CD3ζ and CD28 down-modulation on CD8 T cells during viral infection , 2000 .
[20] C. Hallahan,et al. Maintenance of Large Numbers of Virus-Specific CD8+ T Cells in HIV-Infected Progressors and Long-Term Nonprogressors , 2000, The Journal of Immunology.
[21] Douglas D. Richman,et al. HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function , 2000, The Journal of experimental medicine.
[22] A. De Maria,et al. Multiple HLA-class I-specific inhibitory NK receptor expression and IL-4/IL-5 production by CD8+ T-cell clones in HIV-1 infection. , 2000, Immunology letters.
[23] L. Karlsson,et al. A subpopulation of CD8+ T cells specific for melanocyte differentiation antigens expresses killer inhibitory receptors (KIR) in healthy donors: evidence for a role of KIR in the control of peripheral tolerance , 2000, European journal of immunology.
[24] P. Marrack,et al. Control of homeostasis of CD8+ memory T cells by opposing cytokines. , 2000, Science.
[25] B. Boehm,et al. Direct Visualization of Cytokine-Producing Recall Antigen-Specific CD4 Memory T Cells in Healthy Individuals and HIV Patients1 , 2000, The Journal of Immunology.
[26] C. Figdor,et al. Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses , 2000, Cell.
[27] Douglas S Kwon,et al. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.
[28] J. Mellors,et al. CD8+ T-Cell Gamma Interferon Production Specific for Human Immunodeficiency Virus Type 1 (HIV-1) in HIV-1-Infected Subjects , 2000, Clinical Diagnostic Laboratory Immunology.
[29] B. Kwon,et al. Co‐stimulation of antigen‐specific CD4 T cells by 4‐1BB ligand , 2000, European journal of immunology.
[30] Michael Loran Dustin,et al. Cytoskeletal polarization and redistribution of cell-surface molecules during T cell antigen recognition. , 2000, Seminars in immunology.
[31] D. Nixon,et al. Human Immunodeficiency Virus Type 1- and Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Persist at High Frequency for Prolonged Periods in the Absence of Circulating Peripheral CD4+ T Cells , 2000, Journal of Virology.
[32] U. V. von Andrian,et al. The Cc Chemokine Thymus-Derived Chemotactic Agent 4 (Tca-4, Secondary Lymphoid Tissue Chemokine, 6ckine, Exodus-2) Triggers Lymphocyte Function–Associated Antigen 1–Mediated Arrest of Rolling T Lymphocytes in Peripheral Lymph Node High Endothelial Venules , 2000, The Journal of experimental medicine.
[33] A. Fischer,et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. , 1999, Science.
[34] J. Lisziewicz,et al. Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir. , 1999, The Journal of infectious diseases.
[35] G. Freeman,et al. Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. , 1999, Immunity.
[36] D. Richman,et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. , 1999, Science.
[37] J. Lieberman,et al. Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway. , 1999, Blood.
[38] E. Wolf,et al. CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs , 1999, Cell.
[39] P. Nibbering,et al. Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons. , 1999, The Journal of infectious diseases.
[40] H. Kessler,et al. Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy. , 1999, Journal of immunology.
[41] K. Bottomly,et al. Regulation of naive T cell differentiation by varying the potency of TCR signal transduction. , 1999, Seminars in immunology.
[42] E. Rosenberg,et al. Association between Virus-Specific Cytotoxic T-Lymphocyte and Helper Responses in Human Immunodeficiency Virus Type 1 Infection , 1999, Journal of Virology.
[43] J. Lieberman,et al. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. , 1999, AIDS.
[44] J. Margolick,et al. IL-13 and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression. , 1999, Journal of Immunology.
[45] Mario Roederer,et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients , 1999, Nature Medicine.
[46] D. Baltimore,et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. , 1999, Immunity.
[47] V. Calvez,et al. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. , 1999, AIDS.
[48] J. Schmitz,et al. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. , 1999, Journal of immunology.
[49] C. Pitcher,et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression , 1999, Nature Medicine.
[50] L. Weinberger,et al. Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques , 1999, The Journal of experimental medicine.
[51] B. Walker,et al. Characterization of HIV-1-specific T-helper cells in acute and chronic infection. , 1999, Immunology letters.
[52] Solana,et al. Expression of killer inhibitory receptors on cytotoxic cells from HIV‐1‐infected individuals , 1999, Clinical and experimental immunology.
[53] R. Steinman,et al. Dendritic cells generated from blood monocytes of HIV-1 patients are not infected and act as competent antigen presenting cells eliciting potent T-cell responses. , 1999, Immunology letters.
[54] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.
[55] T. Merigan,et al. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). , 1999, Journal of immunology.
[56] Spyros A. Kalams,et al. The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses , 1998, The Journal of experimental medicine.
[57] J. Altman,et al. Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.
[58] M. Gunn,et al. A high endothelial cell-derived chemokine induces rapid, efficient, and subset-selective arrest of rolling T lymphocytes on a reconstituted endothelial substrate. , 1998, Journal of immunology.
[59] V. Maino,et al. Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis. , 1998, Journal of immunology.
[60] G. Shearer,et al. HIV-induced immunopathogenesis. , 1998, Immunity.
[61] J. Lieberman,et al. Effective lysis of HIV-1-infected primary CD4+ T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[62] A. Sharpe,et al. The role of B7 co‐stimulation in activation and differentiation ofCD4+and CD8+T cells , 1998, Immunological reviews.
[63] J. Sprent,et al. CD40 Ligand-Mediated Interactions Are Involved in the Generation of Memory CD8+ Cytotoxic T Lymphocytes (CTL) but Are Not Required for the Maintenance of CTL Memory following Virus Infection , 1998, Journal of Virology.
[64] C. Bona,et al. Protective Role of Gamma Interferon during the Recall Response to Influenza Virus , 1998, Journal of Virology.
[65] Richard A. Flavell,et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.
[66] Stephen P. Schoenberger,et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions , 1998, Nature.
[67] A. Saito,et al. Lymphocyte-proliferative responses to HIV antigens as a potential measure of immunological reconstitution in HIV disease. , 1998, AIDS research and human retroviruses.
[68] C. Payá,et al. The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection. , 1998, The Journal of clinical investigation.
[69] E. Butcher,et al. 6-C-kine (SLC), a Lymphocyte Adhesion-triggering Chemokine Expressed by High Endothelium, Is an Agonist for the MIP-3β Receptor CCR7 , 1998, The Journal of cell biology.
[70] M. Greenberg,et al. The SH3 domain‐binding surface and an acidic motif in HIV‐1 Nef regulate trafficking of class I MHC complexes , 1998, The EMBO journal.
[71] J. Sprent,et al. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. , 1998, Immunity.
[72] J. Tschopp,et al. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. , 1998, Immunity.
[73] H. Yonekawa,et al. A novel mutant gene involved in T-lymphocyte-specific homing into peripheral lymphoid organs on mouse chromosome 4. , 1998, Blood.
[74] É. Oksenhendler,et al. Low CD83, but normal MHC class II and costimulatory molecule expression, on spleen dendritic cells from HIV+ patients. , 1998, AIDS research and human retroviruses.
[75] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[76] A. Landay,et al. Phenotypic variability of lymphocyte populations in peripheral blood and lymph nodes from HIV-infected individuals and the impact of antiretroviral therapy. DATRI 003 Study Group. Division of AIDS Treatment Research Initiative. , 1998, AIDS research and human retroviruses.
[77] B. Walker,et al. β-Chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans , 1998, Nature.
[78] M. Bevan,et al. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. , 1998, Immunity.
[79] J. Altman,et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.
[80] S. Buchbinder,et al. CD40 ligand and IFN‐γ synergistically restore IL‐12 production in HIV‐infected patients , 1998 .
[81] B. Walker,et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.
[82] J. Lieberman,et al. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex. , 1998, Blood.
[83] L. Moretta,et al. Inhibitory receptors for HLA class I molecules on cytolytic T lymphocytes , 1997, International journal of clinical & laboratory research.
[84] M. Roederer,et al. 8 color, 10-parameter flow cytometry to elucidate complex leukocyte heterogeneity. , 1997, Cytometry.
[85] M. Daucher,et al. Accumulation of human immunodeficiency virus‐specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection , 1997, European journal of immunology.
[86] M. Buchmeier,et al. Interferon-γ Protects against Herpes Simplex Virus Type 1-Mediated Neuronal Death , 1997 .
[87] E. Rosenberg,et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.
[88] J. Levy,et al. CD28 costimulation increases CD8+ cell suppression of HIV replication. , 1997, Journal of immunology.
[89] J. Margolick,et al. Cultured blood dendritic cells retain HIV-1 antigen-presenting capacity for memory CTL during progressive HIV-1 infection. , 1997, Journal of immunology.
[90] M. Rep,et al. Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells , 1997, The Journal of experimental medicine.
[91] A. Fauci,et al. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[92] J. Hoxie,et al. Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors. , 1997, Blood.
[93] H. Ullum,et al. Low production of interferon gamma is related to disease progression in HIV infection: evidence from a cohort of 347 HIV-infected individuals. , 1997, AIDS research and human retroviruses.
[94] T. Orlikowsky,et al. Cytotoxic monocytes in the blood of HIV type 1-infected subjects destroy targeted T cells in a CD95-dependent fashion. , 1997, AIDS research and human retroviruses.
[95] X. Mo,et al. Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68 , 1997, Journal of virology.
[96] J. Lieberman,et al. Recognition of a small number of diverse epitopes dominates the cytotoxic T lymphocytes response to HIV type 1 in an infected individual. , 1997, AIDS research and human retroviruses.
[97] M. McElrath,et al. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[98] A. Haase,et al. A new approach to investigating the relationship between productive infection and cytopathicity in vivo , 1997, Nature Medicine.
[99] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[100] M Guigon,et al. The effect of in vitro human immunodeficiency virus infection on dendritic-cell differentiation and function. , 1996, Blood.
[101] Alan S. Perelson,et al. Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.
[102] W. S. Clark,et al. Early progression of disease in HIV-infected infants with thymus dysfunction. , 1996, The New England journal of medicine.
[103] T. Orlikowsky,et al. The cell surface marker phenotype of macrophages from HIV-1-infected subjects reflects an IL-10-Enriched and IFN-gamma-deprived donor environment. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[104] S. Uccini,et al. Comparison of the Vβ Repertoire in Peripheral Blood and in Lymph Nodes of HIV-Infected Subjects Reveals Skewed Usage Predominantly in CD8+T Cells , 1996 .
[105] J. Metcalf,et al. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. , 1996, The New England journal of medicine.
[106] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[107] W. Blattner,et al. HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression. , 1996, The Journal of clinical investigation.
[108] F. Spertini,et al. Viral load and immunophenotype of cells obtained from lymph nodes by fine needle aspiration as compared with peripheral blood cells in HIV-infected patients. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[109] P. Doherty,et al. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells , 1996, The Journal of experimental medicine.
[110] Marian C. Horzinek,et al. Exacerbated viral hepatitis in IFN-gamma receptor-deficient mice is not suppressed by IL-12. , 1996, Journal of immunology.
[111] A. Sher,et al. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. , 1996, The Journal of infectious diseases.
[112] T. Orlikowsky,et al. Monocytes in HIV type 1-infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity. , 1996, AIDS research and human retroviruses.
[113] M. Pfreundschuh,et al. T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. , 1996, Blood.
[114] H. Eisen,et al. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. , 1996, Immunity.
[115] Paul C. Rogers,et al. From Naive to Memory T Cells , 1996, Immunological reviews.
[116] C. Chougnet,et al. Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-interleukin (IL)-10 antibodies and IL-12. , 1996, The Journal of clinical investigation.
[117] F. Lemonnier,et al. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein , 1996, Nature Medicine.
[118] C. Payá,et al. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes , 1996, Journal of virology.
[119] S. Arya,et al. Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.
[120] K. Metzner,et al. HIV suppression by interleukin-16 , 1995, Nature.
[121] B. Malissen,et al. Tyrosine-phosphorylated T cell receptor zeta chain associates with the actin cytoskeleton upon activation of mature T lymphocytes. , 1995, Immunity.
[122] D. Weissman,et al. Both a precursor and a mature population of dendritic cells can bind HIV. However, only the mature population that expresses CD80 can pass infection to unstimulated CD4+ T cells. , 1995, Journal of immunology.
[123] É. Oksenhendler,et al. Infection frequency of dendritic cells and CD4+ T lymphocytes in spleens of human immunodeficiency virus-positive patients , 1995, Journal of virology.
[124] R. Zinkernagel,et al. Lymphocyte‐mediated Cytotoxicity in vitro and in vivo: Mechanisms and Significance , 1995, Immunological reviews.
[125] P. Sansonetti,et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. , 1995, AIDS research and human retroviruses.
[126] S. Rowland-Jones,et al. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[127] S. Caplan,et al. Cell-surface-expressed T-cell antigen-receptor zeta chain is associated with the cytoskeleton. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[128] C. Benson,et al. Viral Dynamics in Human Immunodeficiency Virus Type 1 Infection , 1995 .
[129] K. Baetz,et al. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re‐filling of the lytic granules and secretion of lytic proteins via a non‐granule pathway , 1995, European journal of immunology.
[130] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[131] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[132] G. Trinchieri,et al. Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[133] A. Pileri,et al. Correlation between disease activity and T‐cell CD3 chain expression in a B‐cell lymphoma , 1994 .
[134] J. Lieberman,et al. Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor. , 1994, AIDS research and human retroviruses.
[135] R. Young,et al. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 , 1994, The Journal of experimental medicine.
[136] P. Henkart. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. , 1994, Immunity.
[137] Michel Klein,et al. Changing Virus‐Host Interactions in the Course of HIV‐1 Infection , 1994, Immunological reviews.
[138] J. Rodgers,et al. Anergy and apoptosis in CD8+ T cells from HIV-infected persons. , 1994, Journal of immunology.
[139] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[140] Sarah Rowland-Jones,et al. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants , 1994, Nature.
[141] L. Filgueira,et al. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor‐infiltrating lymphocytes , 1994, International journal of cancer.
[142] Hans Hengartner,et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.
[143] C. Carini,et al. Interleukin 2-independent interleukin 7 activity enhances cytotoxic immune response of HIV-1-infected individuals. , 1994, AIDS research and human retroviruses.
[144] T. Springer. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.
[145] Dan R. Littman,et al. Signal transduction by lymphocyte antigen receptors , 1994, Cell.
[146] D. Longo,et al. Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. , 1993, Cancer research.
[147] O. Danos,et al. Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef , 1993, Journal of virology.
[148] M. Bevan,et al. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells , 1993, The Journal of experimental medicine.
[149] D. Longo,et al. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. , 1992, Science.
[150] J. Lieberman,et al. Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase. , 1992, Journal of immunology.
[151] R. Steinman,et al. During HIV‐1 infection most blood dendritic cells are not productively infected and can induce allogeneic CD4+ T cells clonal expansion , 1992, Clinical and experimental immunology.
[152] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[153] P. Allen,et al. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. , 1991, Science.
[154] M. Clerici,et al. Multiple patterns of alloantigen presenting/stimulating cell dysfunction in patients with AIDS. , 1991, Journal of immunology.
[155] B. Guy,et al. Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein. , 1991, Journal of immunology.
[156] C. Mackay,et al. Naive and memory T cells show distinct pathways of lymphocyte recirculation , 1990, The Journal of experimental medicine.
[157] S. Patterson,et al. Suppression of immune responses by dendritic cells infected with HIV. , 1989, Immunology.
[158] J. Berzofsky,et al. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals , 1989, Nature.
[159] R. Koup,et al. Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. , 1989, Blood.
[160] B. Guy,et al. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins , 1989, Journal of virology.
[161] B. Autran,et al. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. , 1989, Journal of immunology.
[162] J. Tschopp,et al. Appearance of granule-associated molecules during activation of cytolytic T-lymphocyte precursors by defined stimuli. , 1988, Immunology.
[163] B. Autran,et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders , 1987, Nature.
[164] B. Walker,et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals , 1987, Nature.
[165] J. Levy,et al. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. , 1986, Science.
[166] R. Grant,et al. Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis , 2001, Nature Medicine.
[167] S. Lonial,et al. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. , 2001, Blood.
[168] L. Moretta,et al. HLA-class I-specific inhibitory receptors in HIV-1 infection. , 2000, Human immunology.
[169] J. Lieberman,et al. CD3zeta and CD28 down-modulation on CD8 T cells during viral infection. , 2000, Blood.
[170] J. Strominger,et al. Molecular analyses of the interactions between human NK receptors and their HLA ligands. , 2000, Human immunology.
[171] R. Bellomo,et al. Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function. , 2000, Human immunology.
[172] H. Ploegh,et al. Viral subversion of the immune system. , 2000, Annual review of immunology.
[173] P. Henkart,et al. Cytotoxic cells : basic mechanisms and medical applications , 2000 .
[174] S. Riddell,et al. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells , 1999, Nature Medicine.
[175] F. Sallusto,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.
[176] L. Bradley,et al. T cell memory. , 1998, Annual review of immunology.
[177] M. Greene,et al. Biochemical features of anergic T cells , 1998, Immunologic research.
[178] S. Buchbinder,et al. CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients. , 1998, European journal of immunology.
[179] M. Buchmeier,et al. Interferon-gamma protects against herpes simplex virus type 1-mediated neuronal death. , 1997, Virology.
[180] S. Le Gall,et al. Analysis of Nef-induced MHC-I endocytosis. , 1997, Research in virology.
[181] S. Patterson,et al. Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology. , 1997, Annual review of immunology.
[182] S. Uccini,et al. Comparison of the Vbeta repertoire in peripheral blood and in lymph nodes of HIV-infected subjects reveals skewed usage predominantly in CD8+ T cells. , 1996, Clinical Immunology and Immunopathology.
[183] P. Doherty,et al. Progressive Loss of Cd8 + T Cell-mediated Control of a ~/-herpesvirus in the Absence of Cd4 + T Cells , 1996 .
[184] S. Arya,et al. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. , 1995, Science.
[185] A. Miller,et al. Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.
[186] F. Miedema. Immunological abnormalities in the natural history of HIV infection: mechanisms and clinical relevance. , 1992, Immunodeficiency reviews.
[187] W. Lee,et al. Memory B and T cells. , 1991, Annual review of immunology.